Plantebeskyttelsesmiddelforordningen betragtning 39

English language version pr. 2026-10-28 tier 2 Forordning (EF) nr. 1107/2009, konsolideret tekst pr. 16.06.2026, CELEX 02009R1107-20260616

Studies represent a major investment. This investment should be protected in order to stimulate research. For this reason, tests and studies, other than those involving vertebrate animals, which will be subject to obligatory data sharing, lodged by one applicant with a Member State should be protected against use by another applicant. This protection should, however, be limited in time in order to allow competition. It should also be limited to studies which are genuinely necessary for regulatory purposes, to avoid applicants artificially extending the period of protection by submitting new studies which are not necessary. Business operators, in particular small and medium sized enterprises, should have the same opportunities in respect of market access.

Questions about Plantebeskyttelsesmiddelforordningen betragtning 39? Ask — answers come only from the text, with every claim marked.